These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of resveratrol treatment on graft revascularization after islet transplantation in streptozotocin-induced diabetic mice. Lee EM; Park I; Lee YJ; You YH; Kim JW; Kim MJ; Ahn YB; Kim P; Ko SH Islets; 2018 Jan; 10(1):25-39. PubMed ID: 29333922 [TBL] [Abstract][Full Text] [Related]
6. α-1 Antitrypsin Enhances Islet Engraftment by Suppression of Instant Blood-Mediated Inflammatory Reaction. Wang J; Sun Z; Gou W; Adams DB; Cui W; Morgan KA; Strange C; Wang H Diabetes; 2017 Apr; 66(4):970-980. PubMed ID: 28069642 [TBL] [Abstract][Full Text] [Related]
7. The potential of endothelial colony-forming cells to improve early graft loss after intraportal islet transplantation. Jung HS; Kim MJ; Hong SH; Lee YJ; Kang S; Lee H; Chung SS; Park JS; Park KS Cell Transplant; 2014 Mar; 23(3):273-83. PubMed ID: 23294520 [TBL] [Abstract][Full Text] [Related]
8. Effect of glucose toxicity on intraportal tilapia islet xenotransplantation in nude mice. Al-Jazaeri A; Xu BY; Yang H; Macneil D; Leventhal JR; Wright JR Xenotransplantation; 2005 May; 12(3):189-96. PubMed ID: 15807769 [TBL] [Abstract][Full Text] [Related]
9. Engraftment Site and Effectiveness of the Pan-Caspase Inhibitor F573 to Improve Engraftment in Mouse and Human Islet Transplantation in Mice. Pepper AR; Bruni A; Pawlick R; Wink J; Rafiei Y; Gala-Lopez B; Bral M; Abualhassan N; Kin T; Shapiro AMJ Transplantation; 2017 Oct; 101(10):2321-2329. PubMed ID: 28072753 [TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone treatment does not decrease amyloid deposition in transplanted islets from transgenic mice expressing human islet amyloid polypeptide. Udayasankar J; Zraika S; Aston-Mourney K; Subramanian SL; Brooks-Worrell BM; Taborsky GJ; Hull RL Transplant Proc; 2013 Mar; 45(2):574-9. PubMed ID: 23267797 [TBL] [Abstract][Full Text] [Related]
11. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice. Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017 [TBL] [Abstract][Full Text] [Related]
12. XIAP inhibition of β-cell apoptosis reduces the number of islets required to restore euglycemia in a syngeneic islet transplantation model. Plesner A; Soukhatcheva G; Korneluk RG; Verchere CB Islets; 2010; 2(1):18-23. PubMed ID: 21099289 [TBL] [Abstract][Full Text] [Related]
13. Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice. Merani S; Truong W; Emamaullee JA; Toso C; Knudsen LB; Shapiro AM Endocrinology; 2008 Sep; 149(9):4322-8. PubMed ID: 18511515 [TBL] [Abstract][Full Text] [Related]
14. Systemic overexpression of interleukin-10 fails to protect allogeneic islet transplants in nonobese diabetic mice. Zhang YC; Pileggi A; Molano RD; Wasserfall C; Campbell-Thompson M; Ricordi C; Atkinson MA; Inverardi L Transplantation; 2005 Aug; 80(4):530-3. PubMed ID: 16123729 [TBL] [Abstract][Full Text] [Related]
15. GLP-1 receptor signaling protects pancreatic beta cells in intraportal islet transplant by inhibiting apoptosis. Toyoda K; Okitsu T; Yamane S; Uonaga T; Liu X; Harada N; Uemoto S; Seino Y; Inagaki N Biochem Biophys Res Commun; 2008 Mar; 367(4):793-8. PubMed ID: 18211828 [TBL] [Abstract][Full Text] [Related]
16. Effect of nicotinamide on early graft failure following intraportal islet transplantation. Jung DY; Park JB; Joo SY; Joh JW; Kwon CH; Kwon GY; Kim SJ Exp Mol Med; 2009 Nov; 41(11):782-92. PubMed ID: 19641379 [TBL] [Abstract][Full Text] [Related]
17. Liver ischemia contributes to early islet failure following intraportal transplantation: benefits of liver ischemic-preconditioning. Yin D; Ding JW; Shen J; Ma L; Hara M; Chong AS Am J Transplant; 2006 Jan; 6(1):60-8. PubMed ID: 16433757 [TBL] [Abstract][Full Text] [Related]
18. A preconditioning regimen with a PKCɛ activator improves islet graft function in a mouse transplant model. Hamilton D; Rugg C; Davis N; Kvezereli M; Tafti BA; Busque S; Fontaine M Cell Transplant; 2014; 23(7):913-9. PubMed ID: 23562311 [TBL] [Abstract][Full Text] [Related]
19. A Novel Subcutaneous Site of Islet Transplantation Superior to the Liver. Yasunami Y; Nakafusa Y; Nitta N; Nakamura M; Goto M; Ono J; Taniguchi M Transplantation; 2018 Jun; 102(6):945-952. PubMed ID: 29521877 [TBL] [Abstract][Full Text] [Related]
20. Improvement of Islet Allograft Function Using Cibinetide, an Innate Repair Receptor Ligand. Yao M; Watanabe M; Sun S; Tokodai K; Cerami A; Brines M; Östenson CG; Ericzon BG; Lundgren T; Kumagai-Braesch M Transplantation; 2020 Oct; 104(10):2048-2058. PubMed ID: 32345869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]